Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,117 | -11,719 | -45,901 | -139,896 | -94,155 |
| Depreciation Amortization | 475 | 237 | 942 | 4,820 | 2,927 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 70 | -1,228 |
| Other Working Capital | -1,163 | -1,664 | 866 | -1,320 | -3,520 |
| Other Operating Activity | 1,825 | 1,056 | 4,497 | 17,409 | 12,932 |
| Operating Cash Flow | $-22,980 | $-12,090 | $-39,596 | $-118,917 | $-83,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -214 | -86 | -1,066 | -10,017 | -5,641 |
| Purchase Of Investment | -97,387 | -9,994 | N/A | -396,103 | -264,312 |
| Sale Of Investment | 51,246 | 32,246 | N/A | 381,351 | 256,953 |
| Other Investing Activity | 0 | 0 | 17,198 | 0 | 0 |
| Investing Cash Flow | $-46,355 | $22,166 | $16,132 | $-24,769 | $-13,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57 | 31 | N/A | 63,723 | 51,248 |
| Other Financing Activity | 99,671 | 0 | 126 | -796 | -558 |
| Financing Cash Flow | $99,728 | $31 | $126 | $62,927 | $50,690 |
| Beginning Cash Position | 11,484 | 11,484 | 34,822 | 148,097 | 148,097 |
| End Cash Position | 41,877 | 21,591 | 11,484 | 67,338 | 102,743 |
| Net Cash Flow | $30,393 | $10,107 | $-23,338 | $-80,759 | $-45,354 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,980 | -12,090 | -39,596 | -118,917 | -83,044 |
| Capital Expenditure | -214 | -86 | N/A | -10,017 | -5,641 |
| Free Cash Flow | -23,194 | -12,176 | -39,596 | -128,934 | -88,685 |